Research Topics
| Luc ValiquetteSummaryAffiliation: University of Montreal Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Vardenafil provides reliable efficacy over time in men with erectile dysfunctionFrancesco Montorsi
Instituto San Raffaele, Milan, Italy
Urology 64:1187-95. 2004..The most common adverse events were mild-to-moderate headache, flushing, and rhinitis. CONCLUSIONS: Vardenafil provides reliable efficacy for key erectile function parameters important to patients when continuing oral treatment for ED...- Penetration and maintenance of erection with vardenafil: a time-from-dosing analysisLuc Valiquette
Service d'Urologie, , Montreal, Quebec, Canada
Can J Urol 12:2687-98; discussion 2699. 2005.... - Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled studyLuc Valiquette
Service d Urologie, Hôpital St Luc du CHUM, 1058 rue Saint Denis, Montreal, Quebec, Canada
Mayo Clin Proc 80:1291-7. 2005..To evaluate the reliability, efficacy, and safety of vardenafil, 10 mg, for patients with erectile dysfunction... - First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-IL Valiquette
Department of Urology, Hôpital St Luc du CHUM, Montreal, Quebec, Canada
Int J Clin Pract 60:1378-85. 2006..Vardenafil 10 mg is generally well tolerated and efficacious, providing first-dose success with a consistently high rate of reliability of penetration and maintenance of erection in men with ED and associated comorbidities... 
Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancerUmberto Capitanio
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
Urology 73:1087-91. 2009..To examine the effect the number of biopsy cores taken has on the rate of clinically significant Gleason sum upgrading (GSU) in patients with low-risk prostate cancer...- Baseline prevalence of erectile dysfunction in a prostate cancer screening populationJochen Walz
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
J Sex Med 5:428-35. 2008.... - Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapyGiovanni Lughezzani
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
Int J Radiat Oncol Biol Phys 78:1307-13. 2010.... - The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patientsNaeem Bhojani
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
Int J Radiat Oncol Biol Phys 76:342-8. 2010..We tested this hypothesis in a large French Canadian population-based cohort of prostate cancer patients... - Lower urinary tract symptoms affect one-third of men in a prostate cancer screening populationJochen Walz
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
J Endourol 22:369-76. 2008..Therefore, we assessed baseline rates of LUTS in a PCa screening cohort and assessed which of the International Prostate Symptom Score (IPSS) symptoms had the most detrimental effect on quality of life (QoL)... - A population based assessment of perioperative mortality after cystectomy for bladder cancerHendrik Isbarn
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
J Urol 182:70-7. 2009..Contemporary estimates range from 0.7% to 5.6%. We tested several predictors of perioperative mortality and devised a model for individual perioperative mortality prediction... - A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancerJochen Walz
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
J Clin Oncol 25:3576-81. 2007..To circumvent this problem, we developed a nomogram predicting 10-year LE for patients treated with either radical prostatectomy (RP) or external-beam radiation therapy (EBRT) and compared it with an existing tool... - Responsiveness and clinical utility of the geriatric self-efficacy index for urinary incontinenceCara Tannenbaum
Center for Research, Institut Universitaire de Geriatrie de Montreal, Quebec, Canada
J Am Geriatr Soc 57:470-5. 2009..To report on the responsiveness testing and clinical utility of the 12-item Geriatric Self-Efficacy Index for Urinary Incontinence (GSE-UI)... - Accuracy of life tables in predicting overall survival in patients after radical prostatectomyJochen Walz
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
BJU Int 102:33-8. 2008.... - Ejaculatory disorders may affect screening for prostate cancerJochen Walz
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
J Urol 178:232-7; discussion 237-8. 2007..Therefore, we explored the prevalence of those disorders and associated bother in men without evidence of prostate cancer who participated in an annual prostate cancer screening event... - High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancerClaudio Jeldres
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
Eur Urol 54:97-105. 2008..We examined the effect of annual and cumulative provider volume on the rate of use of secondary therapies after definitive external-beam radiotherapy (EBRT) for localized prostate cancer... - Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissectionMaxine Sun
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
J Urol 183:970-5. 2010.... - Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapyHendrik Isbarn
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada
J Endourol 23:1347-52. 2009..Our objective was to examine the rate and the predictors of 30-day mortality (30dM) after TURP in patients who were exposed to ADT in a large, contemporary Canadian cohort... - Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancerJochen Walz
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
Int J Radiat Oncol Biol Phys 69:88-94. 2007..To test the accuracy of life tables (LTs) in predicting survival in men treated with radiotherapy for localized prostate cancer... - Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancerAndrea Gallina
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
BJU Int 99:1404-8. 2007.... - Screening men for prostate cancer and colorectal cancer: is practice evidence-based?Felix K H Chun
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
Can J Urol 14:3727-33. 2007..We aimed to examine the rate of exposure to previous screening tests for prostate cancer and colorectal cancer in a cohort of men living in Quebec... - Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancerJochen Walz
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
BJU Int 100:1254-8. 2007.... - Impact of chronic prostatitis-like symptoms on the quality of life in a large group of menJochen Walz
Cancer Prognostics and Health Outcomes Unit, and Department of Urology, University of Montreal, Montreal, Quebec, Canada
BJU Int 100:1307-11. 2007.... - Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasiaClaudio Jeldres
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada
J Urol 182:626-32. 2009.... - Training and outcome monitoring in robotic urologic surgeryDaniel Liberman
Department of Urology, University of Montreal Health Center CHUM, Suite 301, 235 Boulevard Rene Levesque Est, Montreal, QC H2X 1N8, Canada
Nat Rev Urol 9:17-22. 2012..Guidelines for outcome monitoring following RS should be developed, to ensure patient safety and sufficient baseline surgeon skill... - Creation and testing of the Geriatric Self-Efficacy Index for Urinary IncontinenceCara Tannenbaum
Centre de Reserche, Institut Universitaire de Geriatrie de Montreal, Montreal, Quebec, Canada
J Am Geriatr Soc 56:542-7. 2008..To report on the content development, construct validity, and reliability testing of the Geriatric Self-Efficacy Index for Urinary Incontinence (GSE-UI)... - Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screeningGeorg Hutterer
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 1058, rue St Denis, Montreal, Que, Canada
Eur J Cancer 43:1180-7. 2007..Body mass index (BMI) may alter serum prostate specific antigen (PSA) and percent free PSA (%fPSA) and may mask the risk of prostate cancer. We investigated the relationship between BMI and PSA or %fPSA... 
Vardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction - RELY-IILuc Valiquette
Hôpital St Luc du CHUM, Montreal, Que
Can Urol Assoc J 2:187-95. 2008..Vardenafil has been shown to be efficacious in patients with erectile dysfunction (ED). We evaluated first-dose and repeat-dose response to vardenafil 20 mg...- Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomyAndrea Gallina
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
Eur Urol 52:98-105. 2007..We hypothesized that contemporary patients, at very low risk of seminal vesicle invasion (SVI), can be highly accurately identified with an equally contemporary SVI nomogram... - A historical review of erectile dysfunctionLuc Valiquette
Department of Surgery (Urology, University of Montreal, , Montreal, Quebec H2X 1N8, Canada
Can J Urol 10:7-11. 2003..This article will evaluate the therapeutic options, from a historical perspective of what has been available, and outline the progress that has been made... - Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrateGregory A Broderick
Department of Urology, Mayo Clinic, Jacksonville, FL 32224, USA
J Sex Med 3:668-75. 2006..Tadalafil, an inhibitor of phosphodiesterase 5 (PDE5), is indicated for treatment of erectile dysfunction. Most tadalafil clinical trials excluded patients with unsuccessful prior treatment with sildenafil citrate (sildenafil)...